PHARMAP 2026 to Showcase Patient-Centric Medicine and Regulatory Harmonization in Amsterdam
核心洞察
The Pharmaceutical Manufacturing and Packaging Congress (PHARMAP 2026 (搜索)) will convene in Amsterdam on April 20-21 to address patient-centricity and regulatory challenges in pharmaceutical manufacturing.
Bayer AG will demonstrate its ALYCE (搜索) platform utilizing AI and data lakehouses for decentralized clinical trials that prioritize patient convenience and engagement.
The congress will feature presentations on global strategies for accelerating access to innovative therapies and the transition from Pharma 4.0 to 5.0 with human-centric digital transformation approaches.
The pharmaceutical industry is undergoing a fundamental transformation toward patient-centricity, with 90% of health systems now ranking patient experience as a top priority. The Pharmaceutical Manufacturing and Packaging Congress (PHARMAP 2026 (搜索)), scheduled for April 20-21 in Amsterdam, will bring together pharmaceutical manufacturers, contract development and manufacturing organizations (CDMOs), and regulatory authorities to address these evolving challenges.
Patient-Centric Innovation Takes Center Stage
Bayer AG is leading the charge in clinical research transformation through its ALYCE (搜索) platform, which utilizes artificial intelligence and data lakehouses to power decentralized trials that prioritize patient convenience. Robin Falter, Value Stream Lead at Bayer, will demonstrate how this vision extends beyond digital solutions to physical products, sharing expertise on patient-centric packaging design.
The congress recognizes that designing for all patients, regardless of individual characteristics, is no longer optional. By integrating patient input from the pre-clinical stage, pharmaceutical companies are fundamentally redefining the design and evaluation of modern medicine.
Research Networks Drive Personalized Medicine
Karel van der Waarde from Lucerne University of Applied Sciences and Arts (HSLU (搜索)) will present findings on whether patients and carers receive relevant medical information. This research spans medical engineering, life sciences, and data science, drawing from HSLU's Interdisciplinary Network (IDN) Health, established in 2024 to unite six schools in creating sustainable healthcare solutions. The network is currently advancing more than 50 collaborative research and publication initiatives.
Joost Groen, Independent Consultant for Patient Empowerment at Sidewise (搜索), will provide strategic insights into optimizing packaging to serve patient needs in today's high-demand market.
Global Regulatory Harmonization and Access
The congress addresses growing concerns about equity in patient-dedicated therapies. Chakravarthi AVPS, Chairman of the Federation of Pharma Entrepreneurs (搜索), will provide an overview of global strategies to accelerate access to innovative therapies, bridging equity, regulation, and technology.
Natalia Vtyurina from ISPE (搜索), an international nonprofit supporting pharmaceutical professionals across 120 countries, will discuss the transition from Pharma 4.0 to 5.0 and how human-centric strategies drive digital transformation.
African Regulatory Milestone
Anne Catherine Diouf, Technical Advisor representing the Senegalese Pharmaceutical Regulatory Agency (搜索), will highlight Senegal's December 2024 achievement as the first French-speaking African country to attain WHO ML3 status for medicines regulation. This milestone is central to Vision 2050's pharmaceutical sovereignty goals.
Supply Chain Standards and Digital Transformation
Sophie Molle, Director of Healthcare Strategic Partnerships at GS1 (搜索), will address global standards in healthcare digitalization. GS1's supply chain standards create a "common language" that enables traceability and strengthens patient safety in pharmaceutical operations.
The congress emphasizes that regulatory institutions rely on harmonization, transparency, and agile science to protect patients without delaying progress, fostering international dialogue to build a safer, more resilient medicine ecosystem.